| Year |
Citation |
Score |
| 2020 |
Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J. Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. Jama Neurology. PMID 32777010 DOI: 10.1001/Jamaneurol.2020.2734 |
0.355 |
|
| 2020 |
Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. Jama Neurology. PMID 32568367 DOI: 10.1001/Jamaneurol.2020.1840 |
0.345 |
|
| 2020 |
Raman R. Statistical methods in handling placebo effect. International Review of Neurobiology. 153: 103-120. PMID 32563284 DOI: 10.1016/Bs.Irn.2020.04.004 |
0.319 |
|
| 2020 |
Sperling RA, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge K, Siemers E, Johnson KA, Aisen PS. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. Jama Neurology. PMID 32250387 DOI: 10.1001/Jamaneurol.2020.0387 |
0.318 |
|
| 2019 |
Henley D, Raghavan N, Sperling R, Aisen P, Raman R, Romano G. Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease. The New England Journal of Medicine. 380: 1483-1485. PMID 30970197 DOI: 10.1056/Nejmc1813435 |
0.347 |
|
| 2019 |
Henley D, Sperling RA, Aisen PS, Raman R, Donohue MC, Ernstrom K, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Brashear R, Novak GP, Thipphawong J, Saad Z, Kolb HC, et al. FTS3-01-04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P873-P874. DOI: 10.1016/J.Jalz.2019.06.4621 |
0.322 |
|
| 2017 |
Rasmusson AM, Marx CE, Jain S, Farfel GM, Tsai J, Sun X, Geracioti TD, Hamner MB, Lohr J, Rosse R, Summerall L, Naylor JC, Cusin C, Lang AJ, Raman R, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology. PMID 28667510 DOI: 10.1007/S00213-017-4649-Y |
0.304 |
|
| 2017 |
Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. PMID 28381506 DOI: 10.1212/Wnl.0000000000003904 |
0.34 |
|
| 2016 |
Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, Meyer B, Jurf J, Altafullah I, Raman R. Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke; a Journal of Cerebral Circulation. PMID 27834742 DOI: 10.1161/Strokeaha.116.014200 |
0.34 |
|
| 2016 |
Bell K, Fann JR, Brockway JA, Cole WR, Bush NE, Dikmen S, Hart T, Lang AJ, Grant G, Gahm GA, Reger MA, St De Lore J, Machamer J, Ernstrom K, Raman R, et al. Telephone Problem Solving for Service Members with Mild Traumatic Brain Injury: A Randomized Clinical Trial. Journal of Neurotrauma. PMID 27579992 DOI: 10.1089/Neu.2016.4444 |
0.302 |
|
| 2016 |
Rosenberg PB, Lanctôt KL, Herrmann N, Mintzer JE, Porsteinsson AP, Sun X, Raman R. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27567808 DOI: 10.3233/Jad-151113 |
0.344 |
|
| 2015 |
Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. PMID 26362286 DOI: 10.1212/Wnl.0000000000002035 |
0.35 |
|
| 2015 |
McAllister TW, Zafonte R, Jain S, Flashman LA, George MS, Grant GA, He F, Lohr JB, Andaluz N, Summerall L, Paulus MP, Raman R, Stein MB. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26361060 DOI: 10.1038/Npp.2015.282 |
0.335 |
|
| 2015 |
Guluma KZ, Liebeskind DS, Raman R, Rapp KS, Ernstrom KB, Alexandrov AV, Shahripour RB, Barlinn K, Starkman S, Grunberg ID, Hemmen TM, Meyer BC, Alexandrov AW. Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke-The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 26347398 DOI: 10.1016/J.Jstrokecerebrovasdis.2015.07.013 |
0.304 |
|
| 2015 |
Spokoyny I, Raman R, Ernstrom K, Kim AJ, Meyer BC, Karanjia NP. Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 26341734 DOI: 10.1016/J.Jstrokecerebrovasdis.2015.04.041 |
0.333 |
|
| 2015 |
Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimer's Research & Therapy. 7: 43. PMID 26120369 DOI: 10.1186/S13195-015-0127-0 |
0.39 |
|
| 2015 |
Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/S13195-015-0122-5 |
0.347 |
|
| 2015 |
Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, Farlow M, Iwatsubo T, Vellas B, Sun X, Ernstrom K, Thomas RG, Aisen PS. Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimer's Research & Therapy. 7: 36. PMID 26064192 DOI: 10.1186/S13195-015-0121-6 |
0.333 |
|
| 2015 |
Spokoyny I, Raman R, Ernstrom K, Khatri P, Meyer DM, Hemmen TM, Meyer BC. Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 24: 1276-81. PMID 25906938 DOI: 10.1016/J.Jstrokecerebrovasdis.2015.01.037 |
0.359 |
|
| 2015 |
Coffman CR, Raman R, Ernstrom K, Herial NA, Schlick KH, Rapp K, Modir RF, Meyer DM, Hemmen TM, Meyer BC. The "DeyeCOM Sign": Predictive Value in Acute Stroke Code Evaluations. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 24: 1299-304. PMID 25891758 DOI: 10.1016/J.Jstrokecerebrovasdis.2015.01.040 |
0.336 |
|
| 2014 |
Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, Cummings J. The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline. Dementia and Geriatric Cognitive Disorders Extra. 4: 509-16. PMID 25685141 DOI: 10.1159/000357775 |
0.364 |
|
| 2014 |
Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PS. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. Jama Neurology. 71: 961-70. PMID 24886908 DOI: 10.1001/Jamaneurol.2014.803 |
0.321 |
|
| 2014 |
Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. The New England Journal of Medicine. 370: 311-21. PMID 24450890 DOI: 10.1056/Nejmoa1312889 |
0.385 |
|
| 2014 |
Lyden PD, Hemmen TM, Grotta J, Rapp K, Raman R. Endovascular therapeutic hypothermia for acute ischemic stroke: ICTuS 2/3 protocol. International Journal of Stroke : Official Journal of the International Stroke Society. 9: 117-25. PMID 24206528 DOI: 10.1111/Ijs.12151 |
0.36 |
|
| 2014 |
Chee B, Raman R, Ernstrom K, Guzik AK, Hemmen TM, Rapp KS, Meyer BC, Meyer DM. Does symptom onset to primary stroke center time goals affect stroke outcome? Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 993-1000. PMID 24103670 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.08.015 |
0.349 |
|
| 2014 |
Spokoyny I, Raman R, Ernstrom K, Meyer BC, Hemmen TM. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 1046-50. PMID 24103663 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.08.023 |
0.349 |
|
| 2014 |
Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D. Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 171-8. PMID 23850331 DOI: 10.1016/J.Jalz.2013.04.003 |
0.304 |
|
| 2014 |
Spokoyny I, Raman R, Ernstrom K, Demaerschalk BM, Lyden PD, Hemmen TM, Guzik AK, Chen JY, Meyer BC. Pooled assessment of computed tomography interpretation by vascular neurologists in the STRokE DOC telestroke network. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 23: 511-5. PMID 23697761 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.04.023 |
0.333 |
|
| 2014 |
Grill JD, Raman R, Ernstrom K, Dowsett S, Hake A, Aisen P, Doody R, Cummings J. P4-174: COMPARING RECRUITMENT AMONG GEOGRAPHIC REGIONS IN MULTINATIONAL ALZHEIMER'S DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 10: P852-P853. DOI: 10.1016/J.Jalz.2014.05.1691 |
0.346 |
|
| 2014 |
Henley DB, Dowsett SA, Chen Y, Liu-Seifert H, Grill JD, Doody R, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. P4-101: REGIONAL VARIATION IN ALZHEIMER'S DISEASE PROGRESSION IN A CLINICAL TRIAL SETTING Alzheimer's & Dementia. 10: P821-P821. DOI: 10.1016/J.Jalz.2014.05.1617 |
0.336 |
|
| 2013 |
Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS, Siemers E, Sethuraman G, Mohs R, et al. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. The New England Journal of Medicine. 369: 341-50. PMID 23883379 DOI: 10.1056/Nejmoa1210951 |
0.372 |
|
| 2013 |
Ovbiagele B, Ernstrom K, Markovic D, Raman R. Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009 Journal of Stroke and Cerebrovascular Diseases. 22: e568-e575. PMID 23871702 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.06.022 |
0.317 |
|
| 2013 |
Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 80: 282-8. PMID 23255824 DOI: 10.1212/Wnl.0B013E31827Debfe |
0.373 |
|
| 2013 |
Huisa BN, Liebeskind DS, Raman R, Hao Q, Meyer BC, Meyer DM, Hemmen TM. Diffusion-weighted imaging-fluid attenuated inversion recovery mismatch in nocturnal stroke patients with unknown time of onset. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: 972-7. PMID 22325574 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.01.004 |
0.331 |
|
| 2012 |
Albright KC, Savitz SI, Raman R, Martin-Schild S, Broderick J, Ernstrom K, Ford A, Khatri R, Kleindorfer D, Liebeskind D, Marshall R, Merino JG, Meyer DM, Rost N, Meyer BC. Comprehensive stroke centers and the 'weekend effect': the SPOTRIAS experience. Cerebrovascular Diseases (Basel, Switzerland). 34: 424-9. PMID 23207423 DOI: 10.1159/000345077 |
0.321 |
|
| 2012 |
Demaerschalk BM, Bobrow BJ, Raman R, Ernstrom K, Hoxworth JM, Patel AC, Kiernan TE, Aguilar MI, Ingall TJ, Dodick DW, Meyer BC. CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist. Stroke; a Journal of Cerebral Circulation. 43: 3095-7. PMID 22984007 DOI: 10.1161/Strokeaha.112.666255 |
0.347 |
|
| 2012 |
Bernick C, Cummings J, Raman R, Sun X, Aisen P. Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. Archives of Neurology. 69: 901-5. PMID 22431834 DOI: 10.1001/Archneurol.2011.3758 |
0.358 |
|
| 2012 |
Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Archives of Neurology. 69: 368-72. PMID 22410444 DOI: 10.1001/Archneurol.2011.830 |
0.343 |
|
| 2012 |
Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. 18: 230-7. PMID 22400970 DOI: 10.1089/Tmj.2011.0116 |
0.354 |
|
| 2012 |
Tafreshi G, Raman R, Ernstrom K, Rapp K, Meyer BC. Late night activity regarding stroke codes: LuNAR strokes. International Journal of Stroke : Official Journal of the International Stroke Society. 7: 473-6. PMID 21714850 DOI: 10.1111/J.1747-4949.2011.00610.X |
0.324 |
|
| 2012 |
Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM. Intravenous tissue plasminogen activator for patients with minor ischemic stroke. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 21: 732-6. PMID 21531576 DOI: 10.1016/J.Jstrokecerebrovasdis.2011.03.009 |
0.342 |
|
| 2012 |
Meyer BC, Raman R, Ernstrom K, Tafreshi GM, Huisa B, Stemer AB, Hemmen TM. Assessment of long-term outcomes for the STRokE DOC telemedicine trial. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 21: 259-64. PMID 20851629 DOI: 10.1016/J.Jstrokecerebrovasdis.2010.08.004 |
0.375 |
|
| 2012 |
Schlick K, Raman R, Hemmen T, Meyer B, Meyer D, Ernstrom K, Ovbiagele B. Stroke Code Patients Are More Likely To Arrive at the Hospital by Ambulance on Weekends vs. Weekdays (P07.018) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.018 |
0.327 |
|
| 2012 |
Hemmen T, Rapp K, Raman R, Concha M, Brössner G, Schmutzhard E, Tafreshi G, Misra V, Cruz-Flores S, Kollmar R, Brown D, Altafullah I, Michel P, Alexandrov A, Smith C, et al. Phase 2/3 study of intravenous thrombolysis and hypothermia for acute treatment of ischemic stroke (ICTuS 2/3) Critical Care. 16. DOI: 10.1186/Cc11271 |
0.301 |
|
| 2012 |
Grill J, Raman R, Ernstrom K, Aisen P, Karlawish J. P3-369: Alzheimer's disease patients with adult child study partners are underrepresented in clinical trials and may experience slower cognitive decline Alzheimer's & Dementia. 8: P585-P586. DOI: 10.1016/J.Jalz.2012.05.1594 |
0.358 |
|
| 2011 |
Hemmen TM, Ernstrom K, Raman R. Two-hour improvement of patients in the National Institute of Neurological Disorders and Stroke trials and prediction of final outcome. Stroke; a Journal of Cerebral Circulation. 42: 3163-7. PMID 21868741 DOI: 10.1161/Strokeaha.110.608919 |
0.358 |
|
| 2011 |
Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR, Thal L, Aisen PS, et al. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Archives of General Psychiatry. 68: 853-61. PMID 21810649 DOI: 10.1001/Archgenpsychiatry.2011.72 |
0.311 |
|
| 2011 |
Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS. Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease. Alzheimer Disease and Associated Disorders. 25: 122-7. PMID 20921876 DOI: 10.1097/Wad.0B013E3181F883B7 |
0.35 |
|
| 2010 |
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. Jama. 304: 1903-11. PMID 21045096 DOI: 10.1001/Jama.2010.1510 |
0.37 |
|
| 2010 |
Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, Fleisher AS. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 412-9. PMID 20813342 DOI: 10.1016/J.Jalz.2009.12.003 |
0.34 |
|
| 2010 |
Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke; a Journal of Cerebral Circulation. 41: 2265-70. PMID 20724711 DOI: 10.1161/Strokeaha.110.592295 |
0.374 |
|
| 2010 |
Huisa BN, Raman R, Ernstrom K, Tafreshi G, Stemer A, Meyer BC, Hemmen T. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 19: 475-9. PMID 20719536 DOI: 10.1016/J.Jstrokecerebrovasdis.2010.03.003 |
0.34 |
|
| 2010 |
Tafreshi GM, Raman R, Ernstrom K, Meyer BC, Hemmen TM. Gender differences in acute stroke treatment: the University of California San Diego experience. Stroke; a Journal of Cerebral Circulation. 41: 1755-7. PMID 20538695 DOI: 10.1161/Strokeaha.110.584136 |
0.341 |
|
| 2010 |
Hemmen TM, Rapp KS, Emond JA, Raman R, Lyden PD. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 19: 290-3. PMID 20471855 DOI: 10.1016/J.Jstrokecerebrovasdis.2009.06.001 |
0.353 |
|
| 2010 |
Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, et al. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 239-46. PMID 20451872 DOI: 10.1016/J.Jalz.2010.03.006 |
0.36 |
|
| 2010 |
Demaerschalk BM, Bobrow BJ, Raman R, Kiernan TE, Aguilar MI, Ingall TJ, Dodick DW, Ward MP, Richemont PC, Brazdys K, Koch TC, Miley ML, Hoffman Snyder CR, Corday DA, Meyer BC, et al. Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial. Stroke; a Journal of Cerebral Circulation. 41: 1251-8. PMID 20431081 DOI: 10.1161/Strokeaha.109.574509 |
0.358 |
|
| 2010 |
Quinn JF, Thomas R, Raman R, Yurko-Mauro K, Bailey-Hall E, Nelson E, Shaw L, Aisen P. Cerebrospinal fluid biomarker outcomes in a trial of docosahexaenoic acid (DHA) for Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1002 |
0.312 |
|
| 2009 |
Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Disease and Associated Disorders. 23: 260-7. PMID 19812469 DOI: 10.1097/Wad.0B013E31819Cb760 |
0.359 |
|
| 2009 |
Raman R, Thomas RG, Weiner MW, Jack CR, Ernstrom K, Aisen PS, Tariot PN, Quinn JF. MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population. Alzheimer Disease and Associated Disorders. 23: 333-6. PMID 19571733 DOI: 10.1097/Wad.0B013E3181Aba588 |
0.343 |
|
| 2009 |
Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke. 40: 2507-11. PMID 19520998 DOI: 10.1161/Strokeaha.108.532069 |
0.32 |
|
| 2009 |
Marson DC, Martin RC, Wadley V, Griffith HR, Snyder S, Goode PS, Kinney FC, Nicholas AP, Steele T, Anderson B, Zamrini E, Raman R, Bartolucci A, Harrell LE. Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer's disease. Journal of the American Geriatrics Society. 57: 806-14. PMID 19453308 DOI: 10.1111/J.1532-5415.2009.02202.X |
0.341 |
|
| 2009 |
Albright KC, Raman R, Ernstrom K, Hallevi H, Martin-Schild S, Meyer BC, Meyer DM, Morales MM, Grotta JC, Lyden PD, Savitz SI. Can comprehensive stroke centers erase the 'weekend effect'? Cerebrovascular Diseases (Basel, Switzerland). 27: 107-13. PMID 19039213 DOI: 10.1159/000177916 |
0.349 |
|
| 2009 |
Quinn JF, Raman R, Thomas RG, Ernstrom K, Yurko-Mauro K, Nelson EB, Shinto L, Nair AK, Aisen P. A clinical trial of docosahexanoic acid (DHA) for the treatment of Alzheimer's disease Alzheimers & Dementia. 5: 84. DOI: 10.1016/J.Jalz.2009.05.215 |
0.338 |
|
| 2008 |
Hamilton JM, Salmon DP, Galasko D, Raman R, Emond J, Hansen LA, Masliah E, Thal LJ. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 22: 729-37. PMID 18999346 DOI: 10.1037/A0012949 |
0.349 |
|
| 2008 |
Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology. 65: 1031-8. PMID 18695053 DOI: 10.1001/Archneur.65.8.1031 |
0.346 |
|
| 2008 |
Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, Thomas RG, Lyden PD. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. The Lancet. Neurology. 7: 787-95. PMID 18676180 DOI: 10.1016/S1474-4422(08)70171-6 |
0.368 |
|
| 2008 |
Meyer BC, Raman R, Chacon MR, Jensen M, Werner JD. Reliability of site-independent telemedicine when assessed by telemedicine-naive stroke practitioners. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 17: 181-6. PMID 18589337 DOI: 10.1016/J.Jstrokecerebrovasdis.2008.01.008 |
0.349 |
|
| 2008 |
Okonkwo OC, Griffith HR, Belue K, Lanza S, Zamrini EY, Harrell LE, Brockington JC, Clark D, Raman R, Marson DC. Cognitive models of medical decision-making capacity in patients with mild cognitive impairment. Journal of the International Neuropsychological Society : Jins. 14: 297-308. PMID 18282327 DOI: 10.1017/S1355617708080338 |
0.345 |
|
| 2008 |
Raman R, Emond J, Thomas RG, Petersen RC, Schneider LS, Aisen PS, Sano M. P4-387: Adding delayed recall to the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog): Sensitivity in a clinical trial for Alzheimer's disease and mild cognitive impairment Alzheimer's & Dementia. 4: T787-T788. DOI: 10.1016/J.Jalz.2008.05.2457 |
0.367 |
|
| 2008 |
Quinn JF, Raman R, Thomas R, Ernstrom K, Yurko-Mauro K, Nelson E, Aisen PS. P4-343: Omega 3 fatty acids and Alzheimer's disease: Trial design and baseline study population characteristics in a clinical trial of docosahexanoic acid for Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2413 |
0.335 |
|
| 2007 |
Meyer BC, Raman R, Rao R, Fellman RD, Beer J, Werner J, Zivin JA, Lyden PD. The STRokE DOC trial technique: 'video clip, drip, and/or ship'. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 281-7. PMID 18705930 DOI: 10.1111/J.1747-4949.2007.00153.X |
0.356 |
|
| 2007 |
Kurlan R, Cummings J, Raman R, Thal L. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism Neurology. 68: 1356-1363. PMID 17452579 DOI: 10.1212/01.Wnl.0000260060.60870.89 |
0.32 |
|
| 2007 |
Tariot PN, Thal L, Jakimovich L, Schneider L, Cummings J, Raman R, Edland S. P-205: Valproate therapy to attenuate the clinical progression of Alzheimer's disease: Design of the ADCS valproate neuroprotection trial Alzheimer's & Dementia. 3: S163-S164. DOI: 10.1016/J.Jalz.2007.04.110 |
0.34 |
|
| 2006 |
Walsh SP, Raman R, Jones KB, Aisen PS. ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI). Alzheimer Disease and Associated Disorders. 20: S170-8. PMID 17135810 DOI: 10.1097/01.Wad.0000213879.55547.57 |
0.374 |
|
| 2006 |
Cummings JL, Raman R, Ernstrom K, Salmon D, Ferris SH. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials. Alzheimer Disease and Associated Disorders. 20: S147-51. PMID 17135808 DOI: 10.1097/01.Wad.0000213872.17429.0F |
0.337 |
|
| 2006 |
Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Disease and Associated Disorders. 20: S124-38. PMID 17135806 DOI: 10.1097/01.Wad.0000213878.47924.44 |
0.332 |
|
| 2006 |
Sattin JA, Olson SE, Liu L, Raman R, Lyden PD. An expedited code stroke protocol is feasible and safe. Stroke; a Journal of Cerebral Circulation. 37: 2935-9. PMID 17095736 DOI: 10.1161/01.Str.0000249057.44420.4B |
0.335 |
|
| 2005 |
Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: A randomized, controlled trial American Journal of Geriatric Psychiatry. 13: 942-949. PMID 16286437 DOI: 10.1097/00019442-200511000-00004 |
0.365 |
|
| 2005 |
Lyden P, Raman R, Liu L, Grotta J, Broderick J, Olson S, Shaw S, Spilker J, Meyer B, Emr M, Warren M, Marler J. NIHSS training and certification using a new digital video disk is reliable. Stroke; a Journal of Cerebral Circulation. 36: 2446-9. PMID 16224093 DOI: 10.1161/01.Str.0000185725.42768.92 |
0.335 |
|
| 2005 |
Meyer BC, Lyden PD, Al-Khoury L, Cheng Y, Raman R, Fellman R, Beer J, Rao R, Zivin JA. Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology. 64: 1058-60. PMID 15781827 DOI: 10.1212/01.Wnl.0000154601.26653.E7 |
0.314 |
|
| 2004 |
Gencheva E, Sloan M, Leurgans S, Raman R, Harris Y, Gorelick P. Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology. 23: 61-66. PMID 14739569 DOI: 10.1159/000073976 |
0.335 |
|
| 2004 |
Tariot PN, Thal L, Jakimovich L, Thomas R, Raman R. P1-322 A multicenter, randomized, double-blind, placebo-controlled trial of valproate for agitation associated with dementia Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80635-3 |
0.319 |
|
| 2002 |
Goetz CG, Leurgans S, Raman R. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Movement Disorders. 17: 283-288. PMID 11921113 DOI: 10.1002/Mds.10024 |
0.328 |
|
| 2001 |
Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology. 57: 2078-2082. PMID 11739829 DOI: 10.1212/Wnl.57.11.2078 |
0.315 |
|
| 2000 |
Goetz CG, Leurgans S, Raman R, Stebbins GT. Objective changes in motor function during placebo treatment in PD Neurology. 54: 710-714. PMID 10680808 DOI: 10.1212/Wnl.54.3.710 |
0.321 |
|
| 2000 |
Chaturvedi S, Raman R, Leurgans S, Gorelick PB. Are African American stroke patients receiving appropriate carotid ultrasound exams Stroke. 32: 378-378. DOI: 10.1161/01.Str.32.Suppl_1.378 |
0.322 |
|
| Show low-probability matches. |